| Nov 18 |
Cosmos Health Integrates Bitcoin and Ethereum as Treasury Reserve Assets
|
| Nov 17 |
Cosmos Health Third Quarter 2024 Earnings: Misses Expectations
|
| Nov 15 |
Cosmos Health Reports Q3 2024 Results: Resilient Revenue and Gross Profit Amid 18.6% Expense Reduction; Stockholders' Equity Up 8.8% to $35M
|
| Nov 12 |
Cosmos Health Issues Letter to Shareholders
|
| Nov 1 |
Cosmos Health's Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, with Gross Profit Rising 21%
|
| Oct 28 |
Cosmos Health files secondary offering of shares
|
| Sep 25 |
Cosmos Health reports robust sales of proprietary brands on Amazon UK
|
| Sep 25 |
Cosmos Health Reports Strong 160% Increase in 2024 YTD Sales on Amazon UK for Its Proprietary Brands
|
| Sep 23 |
Cosmos Health Receives Initial Orders Exceeding $500,000 for C-Scrub in the UK; Future Orders Booked at Accelerated Pace with Strong Profitability Anticipated Due to High Profit Margins
|
| Sep 23 |
Cosmos Health signs exclusivity agreement with Virax Biolabs for mpox kits in India
|
